[{"Assets_0_Q3_USD":37893100000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":2872900000.0,"NetIncomeLoss_3_Q3_USD":6822700000.0,"NetIncomeLoss_1_Q3_USD":1253900000.0,"StockholdersEquity_0_Q3_USD":3382500000.0,"EarningsPerShareBasic_1_Q3_USD":1.37,"EarningsPerShareBasic_3_Q3_USD":7.27,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":913900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":938200000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20191025"}]